The Med-Tech industry is striving to create new technologies that deliver innovative, flexible and efficient diagnostic solutions for healthcare practitioners. It’s one of the largest, growing industries in the UK right now.

Claiming R&D Tax Relief for the development of these technologies can help re-coup a significant proportion of these costs. A recent study found that one in five (21%) innovation active engineering firms (including Med-Tech companies) are not taking advantage of the government’s R&D Tax Credit scheme, potentially missing out on over £10 billion of R&D funding each year.

Developing medical technologies can be a lengthy journey and the time it takes to get a product to market is notably longer than in other industries. This can be due to the large amount of legislation and regulations a med-tech product must adhere to, the clinical trials to prove the technology works, the process of receiving CE marking and getting buy-in from healthcare providers such as the NHS.

Claiming R&D Tax Credits during the development of your new technology allows you to recoup up to 33% of your eligible research and development expenditure as either Corporation Tax relief or a cash repayment.

The financial benefit of your claim can help fund the next stages of your development and maybe even accelerate the process of getting your product to market!

Eligible Activities

The first step to making your R&D Tax Credit claim for Med-Tech Innovation is to identify which activities are eligible for the HMRC schemes. Here are a few examples:

  • Prototype development costs
  • Clinical Trials up to Phase III
  • Testing to satisfy regulatory requirements
  • Software development
  • Hardware development and integration of that with software.
  • Improving the efficiency of existing processes
  • Reducing surgical and recovery time
  • Increasing medical analysis capability

The average R&D Tax Credits claim for Med-Tech businesses is £68,000 per annum and the rapid developments within the industry means that claim values can range from thousands to millions.

This article was written by Medilink Patron, TBAT Innovation.

For more information on Medilink Patronage, click here

Latest Opportunities

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

UKRI unveils new £9 million proof-of-concept fund

The UKRI Proof of Concept funding opportunity aims to support and accelerate the development of…

Peer advice on “demand forecasting strategies”

An established Midlands-based health manufacturer is keen to hear from others about their demand forecasting…

Latest News

Illuminating biology: Advanced imaging and computational techniques transforming medical research at the University of Warwick

Advances in imaging and computational techniques are enabling researchers to discover more than ever before…

From firefighting to future-proofing: Why predictive compliance is key in medical device software

By Medilink Midlands Member Coauthor by Hindsight In today’s fast-paced and highly regulated world of…

IMed Consultancy new whitepaper reveals how to transform gruelling PMS procedures into commercial benefit

IMed Consultancy’s new free whitepaper, “PMS from pain to potential: more than just ticking a…